TrialJournal of hematology & oncology2021

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors.

Jian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.